Internal Server Error

Genio - About the company

Genio is an unfunded company based in Tulsa (United States), founded in 2019 by Thomas E Milner. It operates as an AI-based disease diagnosis tool for healthcare professionals. Genio has not raised any funding yet. The company has 147 active competitors, including 44 funded and 10 that have exited. Its top competitors include companies like Scholar Rock, SamanTree Medical and Lucida Medical.

Company Details

AI-based disease diagnosis tool for healthcare professionals. The company has developed a device called precise that assists with medical diagnosis and analysis of cancerous tissues. It has features for characterization, surgical workflow, tissue analysis, and more.
Website
genio.io
Social
X
Email ID
*****@genio.io
Key Metrics
Founded Year
2019
Location
Stage
Unfunded
Ranked
Employee Count
2 as on Jul 01, 2024
Similar Companies
Sign up to download Genio's company profile

Genio's funding and investors

Genio has not raised any funding rounds yet.

Genio's founders and board of directors

Founder? Claim Profile
The founders of Genio is Thomas E Milner.
Here are the details of Genio's key team members:

Genio's employee count trend

Genio has 2 employees as of Jul 24. Here is Genio's employee count trend over the years:
Employee count trend for Genio
lockUncover Genio's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Genio's Competitors and alternates

Top competitors of Genio include Scholar Rock, SamanTree Medical and Lucida Medical. Here is the list of Top 10 competitors of Genio, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Scholar Rock
Scholar Rock
2012, Cambridge (United States), Public
Developer of Antibody-based drugs for the treatment of primary myopathies
$103M
61/100
2nd
Logo for SamanTree Medical
SamanTree Medical
2014, Lausanne (Switzerland), Series C
Developer of digital microscopy system for high-resolution imaging of tissue
$57.5M
58/100
3rd
Logo for Lucida Medical
Lucida Medical
2019, Cambridge (United Kingdom), Series A
Developer of MRI-based cancer screening technology using artificial intelligence (AI)
$11.5M
58/100
4th
Logo for numares
numares
2004, Regensburg (Germany), Series B
Developer of diagnostic tests using metabolomics and nuclear magnetic resonance spectroscopy
$26.8M
55/100
5th
Logo for Sysmex
Sysmex
1968, Kobe (Japan), Public
Developer of diagnostic instruments, reagents, and related software
-
-
54/100
6th
Logo for Perfint Healthcare
Perfint Healthcare
2005, Chennai (India), Series D
Developer of solutions for image-guided interventional procedures
$41.5M
54/100
7th
Logo for Ionpath
Ionpath
2014, Menlo Park (United States), Series B
Developer of an imaging platform for tissue biopsies
$18M
53/100
8th
Logo for RAYDIAX
RAYDIAX
2021, Magdeburg (Germany), Series A
Developer of therapy-assist CT system for minimally invasive interventions
$8.4M
52/100
9th
Logo for NeoCura
NeoCura
2017, Changping (China), Series A
Provider of an AI-enabled immunotherapy based tumor diagnostic platform
$38.2M
52/100
10th
Logo for IR-MED
IR-MED
2012, Rosh Pinna (Israel), Public
Developer of non-invasive devices for real-time biomarker analysis of blood and tissue
$2.21M
51/100
102nd
Logo for Genio
Genio
2019, Tulsa (United States), Unfunded
AI-based disease diagnosis tool for healthcare professionals
-
-
23/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Genio's competitors? Click here to see the top ones

Genio's Investments and acquisitions

Genio has made no investments or acquisitions yet.

FAQs about Genio

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford